This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Aehr Test Systems (AEHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aehr Test Systems (AEHR) closed the most recent trading day at $42.59, moving -0.7% from the previous trading session.
Aehr Test Systems (AEHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aehr Test Systems (AEHR) closed the most recent trading day at $42.89, moving +0.82% from the previous trading session.
Aehr Test Systems (AEHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Aehr Test Systems (AEHR) closed at $40.94 in the latest trading session, marking a -1.02% move from the prior day.
Is the Options Market Predicting a Spike in Aehr (AEHR) Stock?
by Zacks Premium Research
Investors need to pay close attention to Aehr (AEHR) stock based on the movements in the options market lately.
Is Aehr Test Systems (AEHR) A Buy Heading into Fiscal Q3 Earnings Announcement?
by Bryan Hayes
Semiconductor testing equipment company Aehr Test Systems is set to report fiscal third-quarter earnings results on Thursday after the close.
Aehr Test Systems (AEHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Aehr Test Systems (AEHR) closed the most recent trading day at $32.25, moving -1.83% from the previous trading session.
inTest Corporation (INTT) Surges 8.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
inTest Corporation (INTT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Aehr Test Systems (AEHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aehr Test Systems (AEHR) closed at $31.61, marking a -1.89% move from the previous day.
Aehr Test Systems (AEHR) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Aehr Test Systems (AEHR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Aehr Test Systems (AEHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Aehr Test Systems (AEHR) closed at $32.03 in the latest trading session, marking a -1.78% move from the prior day.
Keysight (KEYS) Q1 Earnings Beat Estimates, Top Line Grows Y/Y
by Zacks Equity Research
Keysight (KEYS) successfully navigated through macroeconomic uncertainty and moderate demand trends and registered a robust top-line expansion owing to its strong operating discipline and diverse portfolio.
Aehr Test Systems (AEHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Aehr Test Systems (AEHR) closed at $35.68 in the latest trading session, marking a +1.65% move from the prior day.
5 Stocks With Recent Price Strength to Maximize Your Gains
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are THR, WFRD, MBIN, ATAT and AEHR.
Aehr Test Systems (AEHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Aehr Test Systems (AEHR) closed at $36.46 in the latest trading session, marking a +1.82% move from the prior day.
Aehr Test Systems (AEHR) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Aehr Test Systems (AEHR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Surging Earnings Estimates Signal Upside for Aehr Test Systems (AEHR) Stock
by Zacks Equity Research
Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Momentum Stock to Buy for February 3rd
by Zacks Equity Research
AEHR, ALGM and ARLP made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 3, 2023.
Is Cognyte Software (CGNT) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Cognyte Software Ltd. (CGNT) and Aehr Test Systems (AEHR) have performed compared to their sector so far this year.
Recent Price Trend in Aehr Test Systems (AEHR) is Your Friend, Here's Why
by Zacks Equity Research
Aehr Test Systems (AEHR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Fujifilm Downgraded on Oceania Market Distress & Macro Risks
by Zacks Equity Research
FUJIFILM Holdings Corporation's (FUJIY) near-term results might weaken due to persistent headwinds within the industry like lower Oceania market sales and stiff industry rivalry.
Philips Inks Telehealth Partnership Deal With American Well
by Zacks Equity Research
Koninklijke Philips N.V.'s (PHG) professional and consumer digital health solutions to be combined with American Well's premium virtual care capabilities for upgrading the former's Avent uGrow application.
Fitbit (FIT) Aids Keller Williams to Expand Wellness Program
by Zacks Equity Research
Fitbit's (FIT) devices are integrated with Keller Williams's wellness program.
Fitbit (FIT) Stock Gains on Settlement of Jawbone Lawsuit
by Zacks Equity Research
Fitbit's (FIT) share price jumps on a litigation settlement with Jawbone.
Aehr Test (AEHR) In Focus: Stock Adds 16.5% in Session
by Zacks Equity Research
Aehr Test Systems (AEHR) moved big last session, as its shares jumped over 16% on the day.